BHMT2
S-methylmethionine--homocysteine S-methyltransferase BHMT2
Also known as: BHMT2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H2M3
- Gene
- BHMT2
- Ensembl
- ENSG00000132840
- Chromosome
- 5
- Canonical length
- 363 aa
- Protein class
- Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Homocysteine is a sulfur-containing amino acid that plays a crucial role in methylation reactions. Transfer of the methyl group from betaine to homocysteine creates methionine, which donates the methyl group to methylate DNA, proteins, lipids, and other intracellular metabolites. The protein encoded by this gene is one of two methyl transferases that can catalyze the transfer of the methyl group from betaine to homocysteine. Anomalies in homocysteine metabolism have been implicated in disorders ranging from vascular disease to neural tube birth defects such as spina bifida. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
363 residues, UniProt reviewed canonical sequence.
>Q9H2M3|BHMT2
1 MAPAGRPGAK KGILERLESG EVVIGDGSFL ITLEKRGYVK AGLWTPEAVI EHPDAVRQLH
61 MEFLRAGSNV MQTFTFSASE DNMESKWEDV NAAACDLARE VAGKGDALVA GGICQTSIYK
121 YQKDEARIKK LFRQQLEVFA WKNVDFLIAE YFEHVEEAVW AVEVLKESDR PVAVTMCIGP
181 EGDMHDITPG ECAVRLVKAG ASIVGVNCRF GPDTSLKTME LMKEGLEWAG LKAHLMVQPL
241 GFHAPDCGKE GFVDLPEYPF GLESRVATRW DIQKYAREAY NLGVRYIGGC CGFEPYHIRA
301 IAEELAPERG FLPPASEKHG SWGSGLDMHT KPWIRARARR EYWENLLPAS GRPFCPSLSK
361 PDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BHMT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 402 nTPM
Expression across tissuesHPA
Tissue
- liver: 402 nTPM
- kidney: 311 nTPM
- epididymis: 36 nTPM
- choroid plexus: 30 nTPM
- adipose tissue: 29 nTPM
- blood vessel: 19 nTPM
Single-cell type
- hepatocytes: 570 nCPM
- proximal tubule cells: 316 nCPM
- epididymal efferent duct absorptive cells: 163 nCPM
- retinal pigment epithelial cells: 145 nCPM
- adipocytes: 114 nCPM
- pituicytes/fscs: 90 nCPM
Immune cell
- neutrophil: 0.8 nTPM
- basophil: 0.7 nTPM
- NK-cell: 0.3 nTPM
- eosinophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
Brain region
- choroid plexus: 27 nTPM
- hypothalamus: 13 nTPM
- midbrain: 12 nTPM
- thalamus: 11 nTPM
- pons: 11 nTPM
- basal ganglia: 9.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- L-methionine salvage
- methylation
- S-adenosylmethionine metabolic process
- S-methylmethionine metabolic process
Molecular functions
- zinc ion binding
- S-methylmethionine-homocysteine S-methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BHMT2 as an antibody target. Whether an autoantibody or antibody against BHMT2 could matter depends on whether native BHMT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BHMT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BHMT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...